BioSpace News Archive

Genetown

Aruna Bio Announces Presentation on Treatment Opportunities for its Neural Exosome Platform and Lead Program, AB126 at the Exosome Based Therapeutic Development Summit

Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced an oral presentation at the Exosome Based Therapeutic Development Summit, being held in Boston, MA from September 5-7, 2023.

September 5, 2023

·

3 min read

Genetown

C4 Therapeutics Announces Chief Financial Officer Succession

C4 Therapeutics, Inc. announced the appointment of Kendra Adams as chief financial officer, effective September 18, 2023.

September 5, 2023

·

5 min read

Biotech Bay

Terns Pharmaceuticals to Participate in Upcoming September 2023 Investor Conferences

Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in September.

September 5, 2023

·

1 min read

New Post Hoc Analysis Showed Substantial Improvement in Observed Estimated Glomerular Filtration Rate (eGFR), in TransCon PTH-Treated Adults with Hypoparathyroidism

Ascendis Pharma A/S (Nasdaq: ASND) today announced new post hoc analysis showing adults with hypoparathyroidism treated with TransCon PTH demonstrated substantial improvement in estimated glomerular filtration rate (eGFR), suggesting improved kidney function.

September 5, 2023

·

7 min read

Pharm Country

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement

Ascendis Pharma A/S and Royalty Pharma plc announced that Ascendis has entered into a $150 million capped synthetic royalty funding agreement with Royalty Pharma based on U.S. net SKYTROFA revenue.

September 5, 2023

·

10 min read

BioMidwest

Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop

Miromatrix Medical Inc. announced its participation in the upcoming Alliance for Regenerative Medicine Tissue Engineering and Therapeutics Workshop held on September 6, 2023.

September 5, 2023

·

1 min read

Biotech Beach

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - September 05, 2023

Mirati Therapeutics, Inc.® announced that the company granted equity awards to 3 new employees with a grant date of September 1, 2023, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan and material to the employee’s acceptance of employment with the company.

September 5, 2023

·

2 min read

CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference

CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 21st Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 18, 2023.

September 5, 2023

·

2 min read

Biotech Bay

Bolt Biotherapeutics to Participate in September Investor Conferences

Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in September:

September 5, 2023

·

1 min read

DBV Technologies to Participate in Upcoming September 2023 Investor Conference

DBV Technologies, a clinical-stage biopharmaceutical company, announced the company will participate in the H.C. Wainwright Annual Global Investment Conference taking place on September 11th −13th in New York, NY.

September 5, 2023

·

1 min read